Postoperative renal replacement therapy after hydroxyethyl starch infusion: A meta-analysis of randomised trials

Netherlands Journal of Critical Care

Volumn 18, Issue 4, 2014, Pages 4-9

  Wilkes, M M ^a   Navickis, R J ^a  

^a NONE

Author keywords

Acute kidney injury; Hydroxyethyl starch; Meta analysis; Randomized trials; Renal replacement therapy; Surgery

Indexed keywords

EID: 84906854640     PISSN: 15693511     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Finfer S, Liu B, Taylor C, et al. Resuscitation fluid use in critically ill adults: an international cross-sectional study in 391 intensive care units. Crit Care. 2010;14:R185.
2. Sakr Y, Payen D, Reinhart K, et al. Effects of hydroxyethyl starch administration on renal function in critically ill patients. Br J Anaesth. 2007;98:216-24.
3. Bayer O, Schwarzkopf D, Doenst T, et al. Perioperative fluid therapy with tetrastarch and gelatin in cardiac surgery-a prospective sequential analysis. Crit Care Med. 2013;41:2532-42.
4. Winkelmayer WC, Glynn RJ, Levin R, Avorn J. Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgery. Kidney Int. 2003;64:1046-9.
5. Rioux JP, Lessard M, de Bortoli B, et al. Pentastarch 10% (250 kDa/0.45) is an independent risk factor of acute kidney injury following cardiac surgery. Crit Care Med. 2009;37:1293-8.
6. Patel M, Niemann C, Sally M, et al. The impact of hydroxyethyl starch use in organ donors after neurologic determination of death on the development of delayed graft function in kidney transplant recipients. Presented at the 85th Annual Meeting of the Pacific Coast Surgical Association, Dana Point, California, USA, 14-17 February 2014.
7. Kastrup M, Carl M, Spies C, Sander M, Markewitz A, Schirmer U. Clinical impact of the publication of S3 guidelines for intensive care in cardiac surgery patients in Germany: results from a postal survey. Acta Anaesthesiol Scand. 2013;57:206-13.
8. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358:125-39.
9. Perner A, Haase N, Guttormsen AB, et al. Hydroxyethyl starch 130/0.4 versus Ringer's acetate in severe sepsis. N Engl J Med. 2012;367:124-34.
10. Myburgh JA, Finfer S, Bellomo R, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012;367:1901-11.
11. Mutter TC, Ruth CA, Dart AB. Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database Syst Rev. 201913;7:CD007594.
12. Zarychanski R, Abou-Setta AM, Turgeon AF, et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis. JAMA. 2013;309:678-88.
13. Food and Drug Administration. 104th Meeting of the Blood Products Advisory Committee. 2012; www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/bloodvaccinesandotherbiologics/bloodproductsadvisorycommittee/ucm325690.pdf; accessed 2014-03-21.
14. Reinhart K, Perner A, Sprung CL, et al. Consensus statement of the ESICM task force on colloid volume therapy in critically ill patients. Intensive Care Med. 2012;38:368-83.
15. Food and Drug Administration. FDA Safety Communication: Boxed Warning on increased mortality and severe renal injury, and additional warning on risk of bleeding, for use of hydroxyethyl starch solutions in some settings. 2013; www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ucm358271.htm; accessed 2014-05-10.
16. European Medicines Agency. Hydroxyethyl-starch solutions (HES) no longer to be used in patients with sepsis or burn injuries or in critically ill patients. HES will be available in restricted patient populations. 2013; www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Solutions_for_infusion_containing_hydroxyethyl_starch/European_Commission_final_decision/WC500162361.pdf; accessed 2014-03-21.
17. Bellomo R, Bion J, Finfer S, Myburgh J, Perner A, Reinhart K. Open letter to the Executive Director of the European Medicines Agency concerning the licensing of hydroxyethyl starch solutions for fluid resuscitation. Br J Anaesth. 2014;112:595-600.
18. Bion J, Bellomo R, Myburgh J, Perner A, Reinhart K, Finfer S. Hydroxyethyl starch: putting patient safety first. Intensive Care Med. 2014;40:256-9.
19. Wilkes MM, Navickis RJ. The Boldt affair: a quandary for meta-analysts. Anesthesiol News. 2013;39:8-9.
20. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539-58.
21. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J. 1997;315:629-34.
22. Altman DG, Bland JM. Interaction revisited: the difference between two estimates. Br Med J. 2003;326:219.
23. Jüni P, Altman DG, Egger M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. Br Med J. 2001;323:42-6.
24. London MJ, Ho JS, Triedman JK, et al. A randomized clinical trial of 10% pentastarch (low molecular weight hydroxyethyl starch) versus 5% albumin for plasma volume expansion after cardiac operations. J Thorac Cardiovasc Surg. 1989;97:785-97.
25. Cittanova ML, Leblanc I, Legendre C, Mouquet C, Riou B, Coriat P. Effect of hydroxyethyl starch in brain dead kidney donors on renal function in kidney- transplant recipients. Lancet. 1996;348:1620-2.
26. Bennett-Guerrero E, Frumento RJ, Mets B, Manspeizer HE, Hirsh AL. Impact of normal saline based versus balanced-salt intravenous fluid replacement on clinical outcomes: a randomized blinded clinical trial. Anesthesiology. 2001;95:A147.
27. Mahmood A, Gosling P, Vohra RK. Randomized clinical trial comparing the effects on renal function of hydroxyethyl starch or gelatine during aortic aneurysm surgery. Br J Surg. 2007;94:427-33.
28. Ando Y, Terao Y, Fukusaki M, et al. Influence of low-molecular-weight hydroxyethyl starch on microvascular permeability in patients undergoing abdominal surgery: comparison with crystalloid. J Anesth. 2008;22:391-6.
29. Godet G, Lehot J-J, Janvier G, Steib A, de Castro V, Coriat P. Safety of HES 130/0.4 (Voluven®) in patients with preoperative renal dysfunction undergoing abdominal aortic surgery: a prospective, randomized, controlled, parallel-group multicentre trial. Eur J Anaesthesiol. 2008;25:986-94.
30. Mukhtar A, Aboulfetouh F, Obayah G, et al. The safety of modern hydroxyethyl starch in living donor liver transplantation: a comparison with human albumin. Anesth Analg. 2009;109:924-30.
31. Ooi JS, Ramzisham AR, Zamrin MD. Is 6% hydroxyethyl starch 130/0.4 safe in coronary artery bypass graft surgery? Asian Cardiovasc Thorac Ann. 2009;17:368-72.
32. Lee JS, Ahn SW, Song JW, Shim JK, Yoo KJ, Kwak YL. Effect of hydroxyethyl starch 130/0.4 on blood loss and coagulation in patients with recent exposure to dual antiplatelet therapy undergoing off-pump coronary artery bypass graft surgery. Circ J. 2011;75:2397-402.
33. Yang J, Wang W-T, Yan L-N, Xu M-Q, Yang J-Y. Alternatives to albumin administration in hepatocellular carcinoma patients undergoing hepatectomy: an open, randomized clinical trial of efficacy and safety. Chin Med J (Engl). 2011;124:1458-64.
34. Hung M-H, Zou C, Lin F-S, Lin C-J, Chan K-C, Chen Y. New 6% hydroxyethyl starch 130/0.4 does not increase blood loss during major abdominal surgery-a randomized, controlled trial. J Formos Med Assoc. 2012; http://dx.doi.org/10.1016/j.jfma.2012.08.002.
35. Gurbuz HA, Durukan AB, Salman N, et al. Hydroxyethyl starch 6%, 130/0.4 vs. a balanced crystalloid solution in cardiopulmonary bypass priming: a randomized, prospective study. J Cardiothorac Surg. 2013;8:71-6.
36. Skhirtladze K, Base EM, Lassnigg A, et al. Comparison of the effects of albumin 5%, hydroxyethyl starch 130/0.4 6%, and Ringer's lactate on blood loss and coagulation after cardiac surgery. Br J Anaesth. 2014;112:255-64.
37. Yates DR, Davies SJ, Milner HE, Wilson RJ. Crystalloid or colloid for goal-directed fluid therapy in colorectal surgery. Br J Anaesth. 2014;112:281-9.
38. Martin C, Jacob M, Vicaut E, Guidet B, Van Aken H, Kurz A. Effect of waxy maize-derived hydroxyethyl starch 130/0.4 on renal function in surgical patients. Anesthesiology. 2013;118:387-94.
39. van der Linden P, James M, Mythen M, Weiskopf RB. Safety of modern starches used during surgery. Anesth Analg. 2013;116:35-48.
40. Gillies MA, Habicher M, Jhanji S, et al. Incidence of postoperative death and acute kidney injury associated with i.v. 6% hydroxyethyl starch use: systematic review and meta-analysis. Br J Anaesth. 2014;112:25-34.
41. Farag E, Argalious M, O'Hara J, Doyle DJ. Safety of HES 130/0.4 not yet settled. Anesth Analg. 2013;117:528-9.
42. Groeneveld AB, Navickis RJ, Wilkes MM. Hydroxyethyl starch 130/0.4 and postoperative acute kidney injury. Anesthesiology. 2013;119:733-5.
43. Takala J, Hartog C, Reinhart K. Safety of modern starches used during surgery: misleading conclusions. Anesth Analg. 2013;117:527-8.
44. Wiedermann CJ. Hydroxyethyl starch 130/0.4: safe for the kidney in surgical patients? Anesthesiology. 2013;119:735-6.
45. Annane D, Siami S, Jaber S, et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA. 2013;310:1809-17.
46. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8:R204-R12.
47. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31.
48. van der Linden P, James M, Mythen M, Weiskopf RB. In response. Anesth Analg. 2013;117:530-1.
49. Steppan J, Hofer S, Funke B, et al. Sepsis and major abdominal surgery lead to flaking of the endothelial glycocalix. J Surg Res. 2011;165:136-41.
50. Bellmann R, Feistritzer C, Wiedermann CJ. Effect of molecular weight and substitution on tissue uptake of hydroxyethyl starch: a meta-analysis of clinical studies. Clin Pharmacokinet. 2012;51:225-36.
51. Wiedermann CJ, Joannidis M. Accumulation of hydroxyethyl starch in human and animal tissues: a systematic review. Intensive Care Med. 2014;40:160-70.